Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Loading…
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma
Carey, Christopher D., Gusenleitner, Daniel, Lipschitz, Mikel, Roemer, Margaretha G.M., Stack, Edward C., Gjini, Evisa, Hu, Xihao, Redd, Robert, Freeman, Gordon J., Neuberg, Donna, Hodi, F. Stephen, Liu, Xiaole Shirley, Shipp, Margaret A., Rodig, Scott J.
Published in Blood (30.11.2017)
Published in Blood (30.11.2017)
Get full text
Journal Article
Loading…
Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients
Subrahmanyam, Priyanka B., Dong, Zhiwan, Gusenleitner, Daniel, Giobbie-Hurder, Anita, Severgnini, Mariano, Zhou, Jun, Manos, Michael, Eastman, Lauren M., Maecker, Holden T., Hodi, F. Stephen
Published in Journal for immunotherapy of cancer (06.03.2018)
Published in Journal for immunotherapy of cancer (06.03.2018)
Get full text
Journal Article
Loading…
Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease
Chapuy, Bjoern, Cheng, Hongwei, Watahiki, Akira, Ducar, Matthew D., Tan, Yuxiang, Chen, Linfeng, Roemer, Margaretha G.M., Ouyang, Jing, Christie, Amanda L., Zhang, Liye, Gusenleitner, Daniel, Abo, Ryan P., Farinha, Pedro, von Bonin, Frederike, Thorner, Aaron R., Sun, Heather H., Gascoyne, Randy D., Pinkus, Geraldine S., van Hummelen, Paul, Wulf, Gerald G., Aster, Jon C., Weinstock, David M., Monti, Stefano, Rodig, Scott J., Wang, Yuzhuo, Shipp, Margaret A.
Published in Blood (05.05.2016)
Published in Blood (05.05.2016)
Get full text
Journal Article
Loading…
Genomic Models of Short-Term Exposure Accurately Predict Long-Term Chemical Carcinogenicity and Identify Putative Mechanisms of Action
Gusenleitner, Daniel, Auerbach, Scott S., Melia, Tisha, Gómez, Harold F., Sherr, David H., Monti, Stefano
Published in PloS one (24.07.2014)
Published in PloS one (24.07.2014)
Get full text
Journal Article
Loading…
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial
Dummer, Reinhard, Brase, Jan C, Garrett, James, Campbell, Catarina D, Gasal, Eduard, Squires, Matthew, Gusenleitner, Daniel, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Chiarion-Sileni, Vanna, Flaherty, Keith, Larkin, James, Robert, Caroline, Kefford, Richard, Kirkwood, John M, Hauschild, Axel, Schadendorf, Dirk, Long, Georgina V
Published in The lancet oncology (01.03.2020)
Published in The lancet oncology (01.03.2020)
Get full text
Journal Article
Loading…
Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with BRAF V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i)
Tawbi, Hussein A, Robert, Caroline, Brase, Jan C, Gusenleitner, Daniel, Gasal, Eduard, Garrett, James, Savchenko, Alexander, Görgün, Güllü, Flaherty, Keith T, Ribas, Antoni, Dummer, Reinhard, Schadendorf, Dirk, Long, Georgina V, Nathan, Paul D, Ascierto, Paolo A
Published in Journal for immunotherapy of cancer (01.06.2022)
Published in Journal for immunotherapy of cancer (01.06.2022)
Get full text
Journal Article
Loading…
Molecular Classification of MYC-Driven B-Cell Lymphomas by Targeted Gene Expression Profiling of Fixed Biopsy Specimens
Carey, Christopher D., Gusenleitner, Daniel, Chapuy, Bjoern, Kovach, Alexandra E., Kluk, Michael J., Sun, Heather H., Crossland, Rachel E., Bacon, Chris M., Rand, Vikki, Cin, Paola Dal, Le, Long P., Neuberg, Donna, Sohani, Aliyah R., Shipp, Margaret A., Monti, Stefano, Rodig, Scott J.
Published in The Journal of molecular diagnostics : JMD (01.01.2015)
Published in The Journal of molecular diagnostics : JMD (01.01.2015)
Get full text
Journal Article
Loading…
GCOD - GeneChip Oncology Database
Liu, Fenglong, White, Joseph A, Antonescu, Corina, Gusenleitner, Daniel, Quackenbush, John
Published in BMC bioinformatics (03.02.2011)
Published in BMC bioinformatics (03.02.2011)
Get full text
Journal Article
Loading…
Effect of first-line spartalizumab + dabrafenib + trametinib on immunosuppressive features detected in peripheral blood and clinical outcome in patients (pts) with advanced BRAF V600–mutant melanoma
Dummer, Reinhard, Biette, Kelly, Gusenleitner, Daniel, Ramesh, Radha, Lebbe, Celeste, Atkinson, Victoria, Mandalà, Mario, Nathan, Paul D., Arance, Ana, Richtig, Erika, Yamazaki, Naoya, Robert, Caroline, Schadendorf, Dirk, Tawbi, Hussein Abdul-Hassan, Ascierto, Paolo Antonio, Ribas, Antoni, Flaherty, Keith, Gasal, Eduard, Brase, Jan C., Long, Georgina V.
Published in Journal of Clinical Oncology (20.05.2020)
Published in Journal of Clinical Oncology (20.05.2020)
Get full text
Journal Article
Loading…
Tumor microenvironment (TME), longitudinal biomarker changes, and clinical outcome in patients (pts) with advanced BRAF V600–mutant melanoma treated with first-line spartalizumab (S) + dabrafenib (D) + trametinib (T)
Dummer, Reinhard, Gusenleitner, Daniel, Campbell, Catarina D., Lebbe, Celeste, Atkinson, Victoria, Mandalà, Mario, Nathan, Paul D., Arance, Ana, Richtig, Erika, Yamazaki, Naoya, Robert, Caroline, Schadendorf, Dirk, Tawbi, Hussein Abdul-Hassan, Ascierto, Paolo Antonio, Ribas, Antoni, Flaherty, Keith, Gasal, Eduard, Brase, Jan C., Long, Georgina V.
Published in Journal of Clinical Oncology (20.05.2019)
Published in Journal of Clinical Oncology (20.05.2019)
Get full text
Journal Article
Loading…
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
Lin, Chia-Chi, Garralda, Elena, Schoeffski, Patrick, Hong, David S., Siu, Lillian L., Martin, Miguel, Maur, Michela, Hui, Rina, Soo, Ross A., Chiu, Joanne, Zhang, Tian, Ma, Brigette, Kyi, Chrisann, Tan, Daniel S.W., Cassier, Philippe A., Sarantopoulos, John, Weickhardt, Andrew, Carvajal, Richard D., Spratlin, Jennifer, Esaki, Taito, Rolland, Frederic, Akerley, Wallace, Deschler-Baier, Barbara, Rispoli, Lawrence, Samant, Tanay S., Chowdhury, Niladri Roy, Gusenleitner, Daniel, Kwak, Eunice L., Askoxylakis, Vasileios, De Braud, Filippo
Published in OncoImmunology (20.12.2023)
Published in OncoImmunology (20.12.2023)
Get full text
Journal Article
Loading…
Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities
Morgan, Elizabeth A., Sweeney, M. Patrick, Tomoka, Tamiwe, Kopp, Nadja, Gusenleitner, Daniel, Redd, Robert A., Carey, Christopher D., Masamba, Leo, Kamiza, Steve, Pinkus, Geraldine S., Neuberg, Donna S., Rodig, Scott J., Milner, Danny A., Weinstock, David M.
Published in Blood advances (29.11.2016)
Published in Blood advances (29.11.2016)
Get full text
Journal Article
Loading…
Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i
Dummer, Reinhard, Lebbé, Celeste, Atkinson, Victoria, Mandalà, Mario, Nathan, Paul D., Arance, Ana, Richtig, Erika, Yamazaki, Naoya, Robert, Caroline, Schadendorf, Dirk, Tawbi, Hussein A., Ascierto, Paolo A., Ribas, Antoni, Flaherty, Keith T., Pakhle, Neha, Campbell, Catarina D., Gusenleitner, Daniel, Masood, Aisha, Brase, Jan C., Gasal, Eduard, Long, Georgina V.
Published in Nature medicine (01.10.2020)
Published in Nature medicine (01.10.2020)
Get full text
Journal Article
Loading…
An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER−/PR−/Her2− Human Breast Cancer Cells
Novikov, Olga, Wang, Zhongyan, Stanford, Elizabeth A., Parks, Ashley J., Ramirez-Cardenas, Alejandra, Landesman, Esther, Laklouk, Israa, Sarita-Reyes, Carmen, Gusenleitner, Daniel, Li, Amy, Monti, Stefano, Manteiga, Sara, Lee, Kyongbum, Sherr, David H.
Published in Molecular pharmacology (01.11.2016)
Published in Molecular pharmacology (01.11.2016)
Get full text
Journal Article
Loading…
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade
Shukla, Sachet A., Bachireddy, Pavan, Schilling, Bastian, Galonska, Christina, Zhan, Qian, Bango, Clyde, Langer, Rupert, Lee, Patrick C., Gusenleitner, Daniel, Keskin, Derin B., Babadi, Mehrtash, Mohammad, Arman, Gnirke, Andreas, Clement, Kendell, Cartun, Zachary J., Van Allen, Eliezer M., Miao, Diana, Huang, Ying, Snyder, Alexandra, Merghoub, Taha, Wolchok, Jedd D., Garraway, Levi A., Meissner, Alexander, Weber, Jeffrey S., Hacohen, Nir, Neuberg, Donna, Potts, Patrick R., Murphy, George F., Lian, Christine G., Schadendorf, Dirk, Hodi, F. Stephen, Wu, Catherine J.
Published in Cell (19.04.2018)
Published in Cell (19.04.2018)
Get full text
Journal Article
Loading…
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Chapuy, Bjoern, Roemer, Margaretha G.M., Stewart, Chip, Tan, Yuxiang, Abo, Ryan P., Zhang, Liye, Dunford, Andrew J., Meredith, David M., Thorner, Aaron R., Jordanova, Ekaterina S., Liu, Gang, Feuerhake, Friedrich, Ducar, Matthew D., Illerhaus, Gerald, Gusenleitner, Daniel, Linden, Erica A., Sun, Heather H., Homer, Heather, Aono, Miyuki, Pinkus, Geraldine S., Ligon, Azra H., Ligon, Keith L., Ferry, Judith A., Freeman, Gordon J., van Hummelen, Paul, Golub, Todd R., Getz, Gad, Rodig, Scott J., de Jong, Daphne, Monti, Stefano, Shipp, Margaret A.
Published in Blood (18.02.2016)
Published in Blood (18.02.2016)
Get full text
Journal Article
Loading…
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
Schöffski, Patrick, Tan, Daniel S W, Martín, Miguel, Ochoa-de-Olza, María, Sarantopoulos, John, Carvajal, Richard D, Kyi, Chrisann, Esaki, Taito, Prawira, Amy, Akerley, Wallace, De Braud, Filippo, Hui, Rina, Zhang, Tian, Soo, Ross A, Maur, Michela, Weickhardt, Andrew, Krauss, Jürgen, Deschler-Baier, Barbara, Lau, Allen, Samant, Tanay S, Longmire, Tyler, Chowdhury, Niladri Roy, Sabatos-Peyton, Catherine A, Patel, Nidhi, Ramesh, Radha, Hu, Tiancen, Carion, Ana, Gusenleitner, Daniel, Yerramilli-Rao, Padmaja, Askoxylakis, Vasileios, Kwak, Eunice L, Hong, David S
Published in Journal for immunotherapy of cancer (01.02.2022)
Published in Journal for immunotherapy of cancer (01.02.2022)
Get full text
Journal Article
Loading…
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma
Griffin, Gabriel K., Weirather, Jason L., Roemer, Margaretha G.M., Lipschitz, Mikel, Kelley, Alyssa, Chen, Pei-Hsuan, Gusenleitner, Daniel, Jeter, Erin, Pak, Christine, Gjini, Evisa, Chapuy, Bjoern, Rosenthal, Michael H., Xu, Jie, Chen, Benjamin J., Sohani, Aliyah R., Lovitch, Scott B., Abramson, Jeremy S., Ishizuka, Jeffrey J., Kim, Austin I., Jacobson, Caron A., LaCasce, Ann S., Fletcher, Christopher D., Neuberg, Donna, Freeman, Gordon J., Hodi, F. Stephen, Wright, Kyle, Ligon, Azra H., Jacobsen, Eric D., Armand, Philippe, Shipp, Margaret A., Rodig, Scott J.
Published in Blood (11.03.2021)
Published in Blood (11.03.2021)
Get full text
Journal Article
Loading…
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
Brase, Jan C., Walter, Robert F.H., Savchenko, Alexander, Gusenleitner, Daniel, Garrett, James, Schimming, Tobias, Varaljai, Renata, Castelletti, Deborah, Kim, Ju, Dakappagari, Naveen, Schultz, Ken, Robert, Caroline, Long, Georgina V., Nathan, Paul D., Ribas, Antoni, Flaherty, Keith T., Karaszewska, Boguslawa, Schachter, Jacob, Sucker, Antje, Schmid, Kurt W., Zimmer, Lisa, Livingstone, Elisabeth, Gasal, Eduard, Schadendorf, Dirk, Roesch, Alexander
Published in Clinical cancer research (15.08.2021)
Published in Clinical cancer research (15.08.2021)
Get full text
Journal Article
Loading…
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
Lin, Chia-Chi, Garralda, Elena, Schöffski, Patrick, Hong, David S., Siu, Lillian L., Martin, Miguel, Maur, Michela, Hui, Rina, Soo, Ross A, Chiu, Joanne, Zhang, Tian, Ma, Brigette, Kyi, Chrisann, Tan, Daniel SW, Cassier, Philippe A., Sarantopoulos, John, Weickhardt, Andrew, Carvajal, Richard D., Spratlin, Jennifer, Esaki, Taito, Rolland, Fréderic, Akerley, Wallace, Deschler-Baier, Barbara, Rispoli, Lawrence, Samant, Tanay S., Chowdhury, Niladri Roy, Gusenleitner, Daniel, Kwak, Eunice L., Askoxylakis, Vasileios, De Braud, Filippo
Published in Oncoimmunology (31.12.2024)
Published in Oncoimmunology (31.12.2024)
Get full text
Journal Article